First Bank & Trust’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

First Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-179	Closed	-$3K	–	290
2018 Q4	$3K	Sell	179 -179	-50%	-$3.67K	﹤0.01%	253
2018 Q3	$8K	Hold	358	–	–	0.01%	234
2018 Q2	$9K	Hold	358	–	–	0.01%	231
2018 Q1	$6K	Hold	358	–	–	﹤0.01%	232
2017 Q4	$7K	Sell	358 -491	-58%	-$7.39K	0.01%	233
2017 Q3	$15K	Sell	849 -737	-46%	-$16.6K	0.01%	217
2017 Q2	$53K	Sell	1,586 -103	-6%	-$3.19K	0.04%	190
2017 Q1	$54K	Sell	1,689 -254	-13%	-$8.67K	0.05%	194
2016 Q4	$70K	Buy	+1,943	New	+$77.6K	0.06%	184

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Bank & Trust's TEVA Position: Q1 2019 in Review

First Bank & Trust sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2019, closing a stake of 179 shares — an estimated $3K sold.

First Bank & Trust first reported a position in TEVA in Q4 2016 and held it in 9 quarters. The position peaked at $70K in Q4 2016. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

First Bank & Trust reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2019 after selling out during the quarter.
First Bank & Trust sold 179 Teva Pharmaceutical Industries Limited shares in Q1 2019, an estimated $3K.
First Bank & Trust first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 9 quarters.
First Bank & Trust's Teva Pharmaceutical Industries Limited position peaked at $70K in Q4 2016.
522 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2019.

Based on First Bank & Trust's 13F filing for Q1 2019, filed 15 Apr 2019.